Swiss Biotech Days Highlights Dutch-Swiss Collaboration in Organ-on-Chip Technology

2025-05-07 bio

Basel, Wednesday, 7 May 2025.
The event will enhance biotech innovation by fostering collaboration between the Netherlands and Switzerland, offering opportunities for networking, and exclusive insights into the Swiss biotech market.

Global Biotech Innovation Hub

The Swiss Biotech Days 2025 in Basel is emerging as a cornerstone event for global biotech innovation, bringing together over 2,500 senior industry experts, 100 exhibitors, and 17 international delegations from more than 40 countries [2]. The event showcases Switzerland’s strong biotech sector, which demonstrated remarkable growth with R&D investments reaching SFr2.6 billion ($3.16 billion) in 2024, up from SFr2.5 billion in 2023 [5].

Organ-on-Chip Technology Focus

A key highlight of the collaboration is the focus on Organ-on-Chip technology, with Health~Holland maintaining a dedicated presence at the event [1]. This strategic partnership builds on recent momentum in the field, as evidenced by the specialized Organ-on-Chip meeting held in Heidelberg on April 29, 2025, where experts discussed advanced microfluidic platforms and AI-driven drug development applications [7].

Strategic Partnership Benefits

The collaboration offers unique advantages for participating companies, including exclusive access to a special side visit on May 7, 2025, designed to provide deeper insights into the Swiss biotech market and facilitate partner meetings [1]. This initiative is particularly significant for the biotech sector, where 95% of Swiss pharma and biotech companies are private entities in early development stages [5].

Future Development Roadmap

Health~Holland is currently conducting a comprehensive market study on Netherlands-Switzerland collaboration, with plans to develop a detailed roadmap for achieving shared objectives [1]. As emphasized by Michael Altorfer, CEO of the Swiss Biotech Association, ‘Switzerland’s collaborative model offers a compelling counterproposal’ to isolationist approaches, highlighting the importance of international partnerships in biotech innovation [5].

Bronnen

biotech collaboration